Session date: 
12/07/2016 - 12:15pm to 1:15pm

Charles Reznikoff, M.D.  
Staff, Addiction Medicine and General Medicine, Henepin County Medical Center
Member, Minnesota State Opioid Work Group and Governor's Medical Cannabis Task Force

Locations:

  • Geffen Auditorium (Live)
  • Broadcast to SMH Alfred M-459 and MA 17-64
  • Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first come, first serve basis


Learning Objectives:

  • Define Mg Morphine Equivalence (MME) and describe its clinical significance
  • Perform a risk assessment on a patient for whom opioids are being considered
  • Identify factors that increase and decrease mortality in patients being prescribed opioids for pain
  • Gain references and resources to further study best opioid prescribing practices

Financial Disclosure:

  • None

Off Label/Investigational Uses:

  • None

Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Mayo Clinic College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota